- Jun 16
MAC Clinical Research has been appointed to accelerate timeline of Phase I/IIa clinical trial
Small Pharma Inc., a neuro-pharmaceutical company focused on psychedelic-assisted therapy, have announced the expansion of its phase...
- Mar 11
MHRA approve launch of DemeRX’s Phase I/IIa trial of ibogaine HCl for treatment of OUD
MAC are excited to be collaborating with DemeRx on their phase 1 trial of Opioid Use Disorder.
- Jan 19
Dr Peter Dewland, has been awarded the Faculty of Pharmaceutical Medicine President’s Medal.
MAC’s Senior Director of Early Phase Research, Dr Peter Dewland, has been awarded the Faculty of Pharmaceutical Medicine President’s...
- Jun 1, 2020
MAC Achieves Cyber Essentials Certification
MAC Clinical Research the UK’s leading clinical trials organisation is proud to announce achieving Cyber Essentials security industry certif
- Dec 16, 2019
PRESS RELEASE: Initiator Pharma reports positive Phase IIa clinical data for IPED2015 in patients w
Initiator Pharma A/S, a clinical-stage biotech company that is developing a novel treatment of erectile dysfunction (ED), today announced...
- Nov 26, 2019
CLINICAL TRIALS EUROPE 2019, BARCELONA
Dr John Connell (Chief Scientific Officer) and MAC's wider team of clinical development experts attended this years Clinical Trials...
- Nov 25, 2019
HOT OFF THE PRESS!! - JOBS - CAREERS WITH MAC
Make a bright future for yourself with a rewarding career at MAC Clinical Research MAC Clinical Research recruits staff on a regular...
- Jan 31, 2019
Peter Dewland, Senior Director of Early Phase Research at MAC Clinical Research, Elected as Chair of
In recognition of 40 years devoted to early phase clinical research, Peter Dewland, BSc, MA, MBBS, FFPM, DCPSA, Senior Director of Early...
- Jan 23, 2019
Meetings & Conferences 2019
Teams of clinical trials experts and research scientists from MAC will be attending a broad range of meetings and conferences in 2019....
- Nov 13, 2018
PARTNERSHIPS IN CLINICAL TRIALS 2018, BARCELONA
"Current challenges in running early phase studies in patients rather than healthy volunteers"
